Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02503007
Other study ID # MTI2015-CS01
Secondary ID
Status Completed
Phase N/A
First received July 15, 2015
Last updated November 24, 2015
Start date July 2015
Est. completion date October 2015

Study information

Verified date October 2015
Source Metabolic Technologies Inc.
Contact n/a
Is FDA regulated No
Health authority Israel: Ministry of Health
Study type Interventional

Clinical Trial Summary

Sustained high-intensity activity, such as survival training with little nourishment available, can result in a loss of muscle performance. This study will examine the effects of a nutritional supplement to maintain muscle and muscle performance during this period.


Description:

Sustained high intensity activity that is often accompanied by sleep and nutrient deprivation is a common characteristic of survival training. Survival training is a requirement in the preparation of pilots, where they learn evasion and survival skills that they may need to avoid capture in a situation in which they have bailed from their plane. The physiological stresses associated with the nature of these operations often results in significant decrements in lean body mass, muscle size and muscle endurance and power. During a sudden evacuation from the aircraft the pilot only takes a small survival bag. There is a limit to what can possibly be put in this bag. However, the ability to provide a dietary supplement specifically targeting muscle may provide an important resource for maintaining muscle mass and performance. Thus, the purpose of this study is to determine the efficacy of 14 days of HMB-FA ingestion on maintaining muscle architecture and muscle performance during 4-days of survival training. In addition, anabolic and catabolic markers of stress, inflammation and muscle damage will be assessed.


Recruitment information / eligibility

Status Completed
Enrollment 27
Est. completion date October 2015
Est. primary completion date September 2015
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 27 Years
Eligibility Inclusion Criteria:

- 18 to 27 Years of age

- Soldier members of Special Operations

- Healthy as assessed by the Unit's Medical Officers

- Subject provides written and dated informed consent to participate

Exclusion Criteria:

- A history of medical or surgical events that may significantly affect the study outcome, including cardiovascular disease, metabolic, renal, hepatic, or musculoskeletal disorders

- Use of medications that may affect the study outcomes

- Use of nutritional supplements (such as protein drinks, creatine, HMB and vitamins) in the 3 months prior to the start of the study

- Subject is currently participating in another clinical trial or has received an investigational product within thirty days prior to screening/enrollment

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Basic Science


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Placebo

HMB-FA


Locations

Country Name City State
Israel IDF Beersheva

Sponsors (2)

Lead Sponsor Collaborator
Metabolic Technologies Inc. Koach Sport and Nutrition

Country where clinical trial is conducted

Israel, 

Outcome

Type Measure Description Time frame Safety issue
Primary Muscle Strength Hand grip strength will be measured using a hand-grip dynamometer. Day 18 No
Secondary Muscle Power Vertical Jump power will be measured using a linear transducer. Day 18 No
Secondary Muscle Morphology Muscle morphology will be measured using a 3.0 Tesla Magnetic Resonance Imaging device. Day 18 No
Secondary Muscle Mass Muscle mass will be performed using bioelectrical impedance Day 18 No
Secondary Blood Biochemical Analysis Blood biochemical analysis will be performed using an ELISA assay. Day 18 No
Secondary Urine Biochemical Analysis Urine biochemical analysis will be performed using an ELISA assay. Day 18 No